PIMS-E, a Subsidiary of PureIMS, Announces Results of a Phase 1 Clinical Trial of Epinephrine Cyclops™, a Dry Powder Inhaler for Early Intervention in Allergic Reactions and Anaphylaxis

Month: October 2020

PIMS-E, a Subsidiary of PureIMS, Announces Results of a Phase 1 Clinical Trial of Epinephrine Cyclops™, a Dry Powder Inhaler for Early Intervention in Allergic Reactions and Anaphylaxis

Delivery via single-inhaler could dramatically expand epinephrine’s clinical utility for emergency self-administration to prevent worsening of early symptoms of anaphylaxis Roden, The Netherlands — October 29th, 2020 — PIMS-E announces the results of a randomized, placebo-controlled phase 1 clinical trial to evaluate inhaled epinephrine in healthy volunteers. The main goal of this trial was to […]